BeyondSpring Pharmaceuticals
Phase 3BeyondSpring Pharmaceuticals is focused on developing innovative cancer therapies to improve clinical outcomes. We are developing treatments in China and the United States.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $274.2M
About
BeyondSpring Pharmaceuticals is focused on developing innovative cancer therapies to improve clinical outcomes. We are developing treatments in China and the United States.
Small Molecules
Funding History
7Total raised:$274.2M
Series C$35MJun 15, 2018
IPO$69.2MSep 20, 2017
IPO$85MMar 9, 2017
Series B$20MJun 15, 2016